Efficacy, Safety, and Biomarkers of Single-Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma

OBJECTIVE. Hepatocellular carcinoma (HCC) is a highly vascularized tumor in which neoangiogenesis contributes to growth and metastasis. We assessed the safety, efficacy, and potential biomarkers of activity of bevacizumab in patients with advanced HCC. METHODS. In this phase II trial, eligible patie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Boige, Valérie, Malka, David, Bourredjem, Abderrahmane, Dromain, Clarisse, Baey, Charlotte, Jacques, Nathalie, Pignon, Jean-Pierre, Vimond, Nadege, Bouvet-Forteau, Nathalie, De Baere, Thierry, Ducreux, Michel, Farace, Françoise
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2012
Matèries:
Hepatobiliary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3425524/
https://ncbi.nlm.nih.gov/pubmed/22707516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0465
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars